144 related articles for article (PubMed ID: 1511679)
1. Molecular dynamics study of a complex between the human histocompatibility antigen HLA-A2 and the IMP58-66 nonapeptide from influenza virus matrix protein.
Rognan D; Zimmermann N; Jung G; Folkers G
Eur J Biochem; 1992 Aug; 208(1):101-13. PubMed ID: 1511679
[TBL] [Abstract][Full Text] [Related]
2. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules.
Bouvier M; Wiley DC
Science; 1994 Jul; 265(5170):398-402. PubMed ID: 8023162
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
Yang X; Chen G; Weng NP; Mariuzza RA
J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling of an antigenic complex between a viral peptide and a class I major histocompatibility glycoprotein.
Rognan D; Reddehase MJ; Koszinowski UH; Folkers G
Proteins; 1992 May; 13(1):70-85. PubMed ID: 1594579
[TBL] [Abstract][Full Text] [Related]
5. A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells.
Latron F; Pazmany L; Morrison J; Moots R; Saper MA; McMichael A; Strominger JL
Science; 1992 Aug; 257(5072):964-7. PubMed ID: 1380181
[TBL] [Abstract][Full Text] [Related]
6. The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove.
Shimojo N; Anderson RW; Mattson DH; Turner RV; Coligan JE; Biddison WE
Int Immunol; 1990; 2(3):193-200. PubMed ID: 2088485
[TBL] [Abstract][Full Text] [Related]
7. Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2.
Guichard G; Connan F; Graff R; Ostankovitch M; Muller S; Guillet JG; Choppin J; Briand JP
J Med Chem; 1996 May; 39(10):2030-9. PubMed ID: 8642561
[TBL] [Abstract][Full Text] [Related]
8. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
Wang Z; Turner R; Baker BM; Biddison WE
J Immunol; 2002 Sep; 169(6):3146-54. PubMed ID: 12218132
[TBL] [Abstract][Full Text] [Related]
9. A structural basis for immunodominant human T cell receptor recognition.
Stewart-Jones GB; McMichael AJ; Bell JI; Stuart DI; Jones EY
Nat Immunol; 2003 Jul; 4(7):657-63. PubMed ID: 12796775
[TBL] [Abstract][Full Text] [Related]
10. Emerging principles for the recognition of peptide antigens by MHC class I molecules.
Matsumura M; Fremont DH; Peterson PA; Wilson IA
Science; 1992 Aug; 257(5072):927-34. PubMed ID: 1323878
[TBL] [Abstract][Full Text] [Related]
11. Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.
Thilo C; Berglund P; Applequist SE; Yewdell JW; Ljunggren HG; Achour A
J Biol Chem; 2006 Mar; 281(13):8950-7. PubMed ID: 16452487
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl group.
Bouvier M; Guo HC; Smith KJ; Wiley DC
Proteins; 1998 Oct; 33(1):97-106. PubMed ID: 9741848
[TBL] [Abstract][Full Text] [Related]
13. The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site.
Khan AR; Baker BM; Ghosh P; Biddison WE; Wiley DC
J Immunol; 2000 Jun; 164(12):6398-405. PubMed ID: 10843695
[TBL] [Abstract][Full Text] [Related]
14. Five viral peptide-HLA-A2 co-crystals. Simultaneous space group determination and X-ray data collection.
Garboczi DN; Madden DR; Wiley DC
J Mol Biol; 1994 Jun; 239(4):581-7. PubMed ID: 7516439
[TBL] [Abstract][Full Text] [Related]
15. Both major and minor peptide-binding pockets in HLA-A2 influence the presentation of influenza virus matrix peptide to cytotoxic T lymphocytes.
Teng JM; Hogan KT
Mol Immunol; 1994 Apr; 31(6):459-70. PubMed ID: 8183284
[TBL] [Abstract][Full Text] [Related]
16. Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue.
Rognan D; Krebs S; Kuonen O; Lamas JR; López de Castro JA; Folkers G
J Comput Aided Mol Des; 1997 Sep; 11(5):463-78. PubMed ID: 9385550
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo study of the effect of beta 2-microglobulin on the binding cleft of the HLA-A2 complex.
Bouzida D; Garnier J; Brower R; Cornette J; DeLisi C
Protein Sci; 1994 Jun; 3(6):911-9. PubMed ID: 8069222
[TBL] [Abstract][Full Text] [Related]
18. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.
Morrison J; Elvin J; Latron F; Gotch F; Moots R; Strominger JL; McMichael A
Eur J Immunol; 1992 Apr; 22(4):903-7. PubMed ID: 1372560
[TBL] [Abstract][Full Text] [Related]
19. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.
Garboczi DN; Hung DT; Wiley DC
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3429-33. PubMed ID: 1565634
[TBL] [Abstract][Full Text] [Related]
20. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.
Parker KC; Bednarek MA; Hull LK; Utz U; Cunningham B; Zweerink HJ; Biddison WE; Coligan JE
J Immunol; 1992 Dec; 149(11):3580-7. PubMed ID: 1331239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
